Citigroup
OCRX

Citigroup’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Citigroup’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,095
Closed -$11K – 8028
2015
Q2 		$11K Buy
3,095
+1,715
+124% +$6.58K ﹤0.01% 6442
2015
Q1 		$7K Buy
1,380
+273
+25% +$1.57K ﹤0.01% 6636
2014
Q4 		$7K Buy
1,107
+107
+11% +$626 ﹤0.01% 6603
2014
Q3 		$5K Hold
1,000
– – ﹤0.01% 6596
2014
Q2 		$8K Buy
+1,000
New +$7.97K ﹤0.01% 6285

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Citigroup's OCRX Position: Q3 2015 in Review

Citigroup sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2015, closing a stake of 3,095 shares — an estimated $11K sold.

Citigroup first reported a position in OCRX in Q2 2014 and held it in 5 quarters. The position peaked at $11K in Q2 2015. 27 funds tracked by Wall St. Rank hold OCRX as of Q3 2015.

  • Citigroup reported no remaining Ocera Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Citigroup sold 3,095 Ocera Therapeutics, Inc. shares in Q3 2015, an estimated $11K.
  • Citigroup first reported a position in Ocera Therapeutics, Inc. in Q2 2014 and held it in 5 quarters.
  • Citigroup's Ocera Therapeutics, Inc. position peaked at $11K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2015.

Based on Citigroup's 13F filing for Q3 2015, filed 13 Nov 2015.